These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33565169)

  • 1. Premature battery depletion of EMBLEM subcutaneous implantable cardioverter-defibrillators.
    Ip JE
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):565-567. PubMed ID: 33565169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature battery depletion due to compromised low-voltage capacitor in a family of defibrillators.
    Montgomery JA; Sensing JY; Saunders SD; Clair WK; Abraham RL; Kanagasundram AN; Ellis CR; Crossley GH; Shoemaker MB; Saavedra P
    Pacing Clin Electrophysiol; 2019 Jul; 42(7):965-969. PubMed ID: 31045260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry.
    Lüker J; Strik M; Andrade JG; Raymond-Paquin A; Elrefai MH; Roberts PR; Pérez ÓC; Kron J; Koneru J; Franqui-Rivera H; Sultan A; Ernst A; Schmitt J; Pott A; Veltmann C; Srinivasan NT; Collinson J; van Stipdonk AMW; Linz D; Fluschnik N; Tönnis T; Haeberlin A; Ploux S; Steven D
    J Interv Card Electrophysiol; 2023 Jan; ():. PubMed ID: 36652082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators.
    Pokorney SD; Greenfield RA; Atwater BD; Daubert JP; Piccini JP
    Heart Rhythm; 2014 Dec; 11(12):2190-5. PubMed ID: 25086256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of re-used pacemakers and implantable cardioverter defibrillators compared with new devices at Groote Schuur Hospital in Cape Town, South Africa.
    Jama ZV; Chin A; Badri M; Mayosi BM
    Cardiovasc J Afr; 2015; 26(4):181-7. PubMed ID: 26407220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.
    Hauser RG; Hayes DL; Epstein AE; Cannom DS; Vlay SC; Song SL; Tyers GF
    Heart Rhythm; 2006 Jun; 3(6):640-4. PubMed ID: 16731462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience.
    Gasperetti A; Schiavone M; Ziacchi M; Vogler J; Breitenstein A; Laredo M; Palmisano P; Ricciardi D; Mitacchione G; Compagnucci P; Bisignani A; Angeletti A; Casella M; Picarelli F; Fink T; Kaiser L; Hakmi S; Calò L; Pignalberi C; Santini L; Lavalle C; Pisanò E; Olivotto I; Tondo C; Curnis A; Dello Russo A; Badenco N; Steffel J; Love CJ; Tilz R; Forleo G; Biffi M
    Heart Rhythm; 2021 Dec; 18(12):2050-2058. PubMed ID: 34271173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.
    Thijssen J; Borleffs CJ; van Rees JB; Man S; de Bie MK; Venlet J; van der Velde ET; van Erven L; Schalij MJ
    Heart Rhythm; 2012 Apr; 9(4):513-9. PubMed ID: 22094073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Real life" longevity of implantable cardioverter-defibrillator devices.
    Manolis AS; Maounis T; Koulouris S; Vassilikos V
    Clin Cardiol; 2017 Sep; 40(9):759-764. PubMed ID: 28543134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.
    Quast ABE; van Dijk VF; Yap SC; Maass AH; Boersma LVA; Theuns DA; Knops RE
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1010-1016. PubMed ID: 29626366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators.
    Ozcan C; Rottman JN; Heist EK; Guy ML; Ellinor PT; Singh J; Milan DJ; Danik SB; Barrett CD; Mansour M; Ruskin JN; Mela T
    Heart Rhythm; 2012 May; 9(5):717-20. PubMed ID: 22172318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longevity of implantable cardioverter-defibrillators in a single-center population.
    Seegers J; Expósito PM; Lüthje L; Fischer T; Lueken M; Wenk H; Sossalla ST; Hasenfuss G; Zabel M
    J Interv Card Electrophysiol; 2015 Nov; 44(2):179-86. PubMed ID: 26253815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.
    von Gunten S; Schaer BA; Yap SC; Szili-Torok T; Kühne M; Sticherling C; Osswald S; Theuns DA
    Europace; 2016 May; 18(5):710-7. PubMed ID: 26609076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation subcutaneous implantable cardioverter defibrillator and intermuscular two-incision implantation technique in patients with Arrhythmogenic cardiomyopathy: 3-year follow-up.
    Migliore F; Pittorru R; De Lazzari M; Cipriani A; Bauce B; Marra MP; Giacomin E; Dall'Aglio PB; Accinelli S; Iliceto S; Corrado D
    Int J Cardiol; 2023 Jul; 382():33-39. PubMed ID: 37059308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
    Doppalapudi H; Barrios J; Cuellar J; Gannon M; Yamada T; Kumar V; Maddox WR; Plumb VJ; Brown TM; McElderry HT
    J Cardiovasc Electrophysiol; 2017 May; 28(5):552-558. PubMed ID: 28181727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.